Enrique Soto-Perez-de-Celis1,2, Can-Lan Sun1, William P Tew3, Supriya Gupta Mohile4, Ajeet Gajra5, Heidi D Klepin6, Cynthia Owusu7, Cary Philip Gross8, Hyman B Muss9, Stuart M Lichtman3, Andrew E Chapman10, Harvey Jay Cohen11, William Dale12, Heeyoung Kim1, Simone Fernandes1, Vani Katheria1, Arti Hurria1. 1. Cancer and Aging Research Program, City of Hope, Duarte, California. 2. Department of Geriatrics, Salvador Zubiran National Institute of Medical Science and Nutrition, Mexico City, Mexico. 3. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 4. Department of Medicine, University of Rochester Medical Center, Rochester, New York. 5. ICON Clinical Research, North Wales, Pennsylvania. 6. Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina. 7. Department of Medicine, Case Western Reserve University, Cleveland, Ohio. 8. Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut. 9. University of North Carolina School of Medicine, Chapel Hill, North Carolina. 10. Jefferson Senior Adult Oncology Center, Thomas Jefferson University, Philadelphia, Pennsylvania. 11. Center for the Study of Aging & Human Development, Duke University Medical Center, Durham, North Carolina. 12. Department of Supportive Care Medicine, City of Hope, Duarte, California.
Abstract
BACKGROUND: Hearing and visual impairments are common among community-dwelling older adults, and are associated with psychological, functional, and cognitive deficits. However, to the authors' knowledge, little is known regarding their prevalence among older patients with cancer. METHODS: The current study was a secondary analysis combining 2 prospective cohorts of adults aged ≥65 years with solid tumors who were receiving chemotherapy. The authors assessed the association between patient-reported hearing and/or visual impairment (defined as fair/poor grading by self-report) and physical function, instrumental activities of daily living (IADLs), anxiety, depression, and cognition. Descriptive analyses were conducted to summarize patient and treatment characteristics. One-way analysis of variance and chi-square tests were conducted as appropriate to examine differences between patients with and without sensory impairments. Logistic regression was used to analyze associations between sensory impairments and outcomes. RESULTS: Among 750 patients with a median age of 72 years who had solid tumors (29% with breast/gynecological tumors, 28% with lung tumors, and 27% with gastrointestinal tumors), approximately 18% reported hearing impairment alone, 11% reported visual impairment alone, and 7% reported dual sensory impairment. Hearing impairment was associated with IADL dependence (odds ratio [OR], 1.9), depression (OR, 1.6), and anxiety (OR, 1.6). Visual impairment was associated with IADL dependence (OR, 1.9), poor physical function (OR, 1.9), and depression (OR, 2.5). Dual impairment was associated with IADL dependence (OR, 2.8), anxiety (OR, 2.3), depression (OR, 2.5), and cognitive impairment (OR, 3.2). CONCLUSIONS: Sensory impairment is common among older adults with cancer. Patients with sensory impairment are more likely to have functional, psychological, and cognitive deficits. Interventions aimed at improving the vision and hearing of older adults with cancer should be studied. Cancer 2018.
BACKGROUND: Hearing and visual impairments are common among community-dwelling older adults, and are associated with psychological, functional, and cognitive deficits. However, to the authors' knowledge, little is known regarding their prevalence among older patients with cancer. METHODS: The current study was a secondary analysis combining 2 prospective cohorts of adults aged ≥65 years with solid tumors who were receiving chemotherapy. The authors assessed the association between patient-reported hearing and/or visual impairment (defined as fair/poor grading by self-report) and physical function, instrumental activities of daily living (IADLs), anxiety, depression, and cognition. Descriptive analyses were conducted to summarize patient and treatment characteristics. One-way analysis of variance and chi-square tests were conducted as appropriate to examine differences between patients with and without sensory impairments. Logistic regression was used to analyze associations between sensory impairments and outcomes. RESULTS: Among 750 patients with a median age of 72 years who had solid tumors (29% with breast/gynecological tumors, 28% with lung tumors, and 27% with gastrointestinal tumors), approximately 18% reported hearing impairment alone, 11% reported visual impairment alone, and 7% reported dual sensory impairment. Hearing impairment was associated with IADL dependence (odds ratio [OR], 1.9), depression (OR, 1.6), and anxiety (OR, 1.6). Visual impairment was associated with IADL dependence (OR, 1.9), poor physical function (OR, 1.9), and depression (OR, 2.5). Dual impairment was associated with IADL dependence (OR, 2.8), anxiety (OR, 2.3), depression (OR, 2.5), and cognitive impairment (OR, 3.2). CONCLUSIONS:Sensory impairment is common among older adults with cancer. Patients with sensory impairment are more likely to have functional, psychological, and cognitive deficits. Interventions aimed at improving the vision and hearing of older adults with cancer should be studied. Cancer 2018.
Authors: Janet S Choi; Joshua Betz; Jennifer Deal; Kevin J Contrera; Dane J Genther; David S Chen; Fiona E Gispen; Frank R Lin Journal: J Aging Health Date: 2015-11-09
Authors: Bruna Galobardes; Mary Shaw; Debbie A Lawlor; John W Lynch; George Davey Smith Journal: J Epidemiol Community Health Date: 2006-01 Impact factor: 3.710
Authors: Bamini Gopinath; Julie Schneider; Catherine M McMahon; George Burlutsky; Stephen R Leeder; Paul Mitchell Journal: PLoS One Date: 2013-03-04 Impact factor: 3.240
Authors: Piers Dawes; Richard Emsley; Karen J Cruickshanks; David R Moore; Heather Fortnum; Mark Edmondson-Jones; Abby McCormack; Kevin J Munro Journal: PLoS One Date: 2015-03-11 Impact factor: 3.240
Authors: Niranjani Nagarajan; Lama Assi; V Varadaraj; Mina Motaghi; Yi Sun; Elizabeth Couser; Joshua R Ehrlich; Heather Whitson; Bonnielin K Swenor Journal: BMJ Open Date: 2022-01-06 Impact factor: 3.006
Authors: Marie A Flannery; Eva Culakova; Beverly E Canin; Luke Peppone; Erika Ramsdale; Supriya G Mohile Journal: J Clin Oncol Date: 2021-05-27 Impact factor: 44.544
Authors: Sandra Silva; Ana Bártolo; Isabel M Santos; Anabela Pereira; Sara Monteiro Journal: Int J Environ Res Public Health Date: 2022-03-14 Impact factor: 3.390